P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

Anders Rosendal Korshoej; Slávka Lukácová; Jens Christian Hedemann Sørensen; Frederik Lundgaard Hansen; Nikola Mikic; Axel Thielscher; Søren Ole Stigaard Cortnum; Trine Lignell Guldberg; Yasmin Lassen-Ramshad; Christian Rahbek; Kåre Severinsen; Gorm von Oettingen

P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

Anders Rosendal Korshoej, Slávka Lukácová, Jens Christian Hedemann Sørensen, Frederik Lundgaard Hansen, Nikola Mikic, Axel Thielscher, Søren Ole Stigaard Cortnum, Trine Lignell Guldberg, Yasmin Lassen-Ramshad, Christian Rahbek, Kåre Severinsen, Gorm von Oettingen

Department of Clinical Medicine - The Department of Neurosurgery

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

Original language	Danish
Journal	Neuro-Oncology
ISSN	1522-8517
Publication status	Published - Sept 2018

Cite this

Korshoej, A. R., Lukácová, S., Sørensen, J. C. H., Lundgaard Hansen, F., Mikic, N., Thielscher, A., Cortnum, S. O. S., Guldberg, T. L., Lassen-Ramshad, Y., Rahbek, C., Severinsen, K., & Oettingen, G. V. (2018). P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1). Neuro-Oncology.

@article{8e55bd4014a94ee290e0d21b548e234f,

title = "P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)",

author = "Korshoej, {Anders Rosendal} and Sl{\'a}vka Luk{\'a}cov{\'a} and S{\o}rensen, {Jens Christian Hedemann} and {Lundgaard Hansen}, Frederik and Nikola Mikic and Axel Thielscher and Cortnum, {S{\o}ren Ole Stigaard} and Guldberg, {Trine Lignell} and Yasmin Lassen-Ramshad and Christian Rahbek and K{\aa}re Severinsen and Oettingen, {Gorm von}",

year = "2018",

month = sep,

language = "Dansk",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

Korshoej, AR, Lukácová, S, Sørensen, JCH, Lundgaard Hansen, F, Mikic, N, Thielscher, A, Cortnum, SOS, Guldberg, TL, Lassen-Ramshad, Y, Rahbek, C, Severinsen, K & Oettingen, GV 2018, 'P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)', Neuro-Oncology.

P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1). / Korshoej, Anders Rosendal; Lukácová, Slávka; Sørensen, Jens Christian Hedemann et al.
In: Neuro-Oncology, 09.2018.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

AU - Korshoej, Anders Rosendal

AU - Lukácová, Slávka

AU - Sørensen, Jens Christian Hedemann

AU - Lundgaard Hansen, Frederik

AU - Mikic, Nikola

AU - Thielscher, Axel

AU - Cortnum, Søren Ole Stigaard

AU - Guldberg, Trine Lignell

AU - Lassen-Ramshad, Yasmin

AU - Rahbek, Christian

AU - Severinsen, Kåre

AU - Oettingen, Gorm von

PY - 2018/9

Y1 - 2018/9

M3 - Konferenceabstrakt i tidsskrift

SN - 1522-8517

JO - Neuro-Oncology

JF - Neuro-Oncology

ER -